Oculis has closed an oversubscribed USD 57m Series C financing round. It was co-led by new investors BVCF Management and Hyfinity Investments, with VI Partners and Wille AG joining the company’s existing investors, Bay
Tags :Vischer
Relief Therapeutics Holding and APR Applied Pharma Research have signed a binding term sheet for relief to acquire all outstanding shares of APR. According to the Term Sheet, the APR shareholders will receive from Relief
Drägerwerk AG & Co. KGaA, an international operator in the fields of medical and safety technology, has acquired a majority stake in the Swiss-based start-up medical technology company STIMIT. VISCHER advised Stimit and the
Unsere Champions, a successful operator of day nurseries and kindergartens in southern Germany, acquired, for the first time, various childcare facilities in the German-speaking part of Switzerland from private sellers. Vischer advised Unsere Champions on
The VISCHER team led by partner Dr. Adrian Dörig (Corporate Finance - pictured) included Dr. Peter Kühn (Counsel, Corporate / M & A), Flavio Langenegger (Associate, Corporate / M & A), Florian Kambor (Junior Associate, Corporate / M&
The Pestalozzi team included Christian Leuenberger (Lead Partner - Capital Markets, Corporate/M&A - pictured), Severin Roelli (Partner - Corpoarte/M&A), Manu Ferro (Associate - Banking & Finance).
VISCHER advised CITIC on all Swiss law matters. The team was led by Benedict F. Christ (partner, corporate/M&A - pictured) and included Lukas Zuest (counsel, head China Desk, corporate/M&A), Aleksandra Simic (
VISCHER advised MCAM as lead counsel. The team was led by partner Felix W. Egli (Corporate/M&A - pictured) and included partner Christoph Niederer (Tax), managing associate Thomas Steiner-Krizaj (Corporate/M&A) , counsel Peter
The team consists of Christian Wyss (Partner, Corporate / M&A), Sebastian Flückiger (Associate, Corporate / M&A), and Adrian Briner (Associate, Tax).
The VISCHER team, led by partner Adrian Dörig (Corporate Finance - pictured) included Peter Kühn (Counsel, Corporate / M & A), Moritz Jäggy (Managing Associate, Corporate / M&A), Florian Angstmann (Associate, Corporate / M&A),
